WW
Insider
William D. Waddill
DirectorWilliam D. Waddill (Director) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Protagonist Therapeutics, Inc. (PTGX). The largest single filing was $1.7M of PTGX (20,000 sh × $83.68, as filed), executed Feb 6.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
7
0 buys · 7 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.1M
shares × price, as filed
Last traded
Jun 23
Filed Jun 25
Median ADV $107.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
7 filings
Sector per market data · by filing · past 12 months
Most traded names
PTGXRecent filings
PTGXSALE
Protagonist Therapeutics, Inc.
View filing →
$1.1M9,000 sh × $117.94
Exec Jun 23
Filed Jun 25 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $969K
9,000 sh × $107.68
Exec Jun 10
Filed Jun 11 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $897K
9,000 sh × $99.64
Exec May 29
Filed Jun 1 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $1.7M
20,000 sh × $83.68
Exec Feb 6
Filed Feb 6 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. View filing → $532K
7,867 sh across 2 lots
Exec Dec 19 2025
Filed Dec 23 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $979K
12,000 sh across 2 lots
Exec Oct 10 2025
Filed Oct 14 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $257K
4,000 sh × $64.25
Exec Sep 22 2025
Filed Sep 24 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $237K
4,000 sh × $59.25
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET More filings →